Table 6.
Resistance | Target Gene | DEC | EAEC | EPEC | ETEC | EIEC | Stx Negative EHEC O157:H7 |
---|---|---|---|---|---|---|---|
Sulfonamide | Sul2 | 18/23 (78.2%) | 9/10 (90%) | 5/5 (100%) | 2/3 (66.6%) | 1/2 (50%) | 1/3 (33.3%) |
Sul1 | 14/23(60.8%) | 6/10 (60%) | 4/5 (80%) | 1/3 (33.3%) | 1/2 (50%) | 2/3 (66.6%) | |
ESBL+ | blaTEM | 18/18 (100%) | 9/9 (100%) | 5/5 (100%) | 2/2 (100%) | 1/1 (100%) | 1/1 (100%) |
blaCTX-M-15 | 17/18 (94.4%) | 8/9 (88.8%) | 5/5 (100%) | 2/2 (100%) | 1/1 (100%) | 1/1 (100%) | |
blaCTX-M-1 | 12/18 (66.6%) | 6/9 (66.6%) | 4/5 (80%) | 1/2 (50%) | 1/1 (100%) | 0% | |
blaCTX-M-14 | 12/18 (66.6%) | 7/9 (77.7%) | 4/5 (80%) | 1/2 (50%) | 0% | 0% | |
blaSHV | 6/18 (33.3%) | 3/9 (33.3%) | 3/5 (60%) | 0% | 0% | 1/1 (100%) | |
blaCTX-M-2 | 6/18 (33.3%) | 3/9 (33.3%) | 2/5 (40%) | 1/2 (50%) | 0% | 0% | |
blaCTX-M-8 | 0% | 0% | 0% | 0% | 0% | 0% | |
blaCIT | 4/9 (44.4%) | 2/6 (33.3%) | 1/2 (50%) | 1/1 (100%) | – | – | |
blaDHA | 4/9 (44.4%) | 2/6 (33.3%) | 1/2 (50%) | 1/1 (100%) | – | – | |
blaCMY-2 | 3/9 (44.4%) | 1/6 (100%) | 1/2 (100%) | 1/1 (100%) | – | – | |
blaACC | 1/9 (11.1%) | 1/6 (16.6%) | 0% | 0% | – | – | |
blaFOX | 0% | 0% | 0% | 0% | – | – | |
blaMOX | 0% | 0% | 0% | 0% | – | – | |
Fluoroquinolone | gyrA | 20/30 (66.6%) | 8/11 (72.7%) | 7/8 (87.5%) | 2/5 (40%) | 1/3 (33.3%) | 2/3 (66.6%) |
parC | 18/30 (60%) | 7/11 (63.6%) | 7/8 (87.5%) | 2/5 (40%) | 1/3 (33.3%) | 1/3 (33.3%) | |
qnrS | 18/30 (60%) | 7/11 (63.6%) | 6/8 (75%) | 2/5 (40%) | 1/3 (33.3%) | 2/3 (66.6%) | |
qnrA | 2/30 (6.6%) | 1/11 (9%) | 1/8 (12.5%) | 0% | 0% | 0% | |
qnrB | 0% | 0% | 0% | 0% | 0% | 0% | |
Integrase | Int1 | 19/32 (59.3%) | 6/11 (54.5%) | 6/9 (66.6%) | 4/6 (66.6%) | 2/3 (66.6%) | 1/3 (33.3%) |
Int2 | 13/32 (40.6%) | 4/11 (36.3%) | 7/9 (77.7%) | 1/6 (16.6%) | 0% | 1/3 (33.3%) | |
Int3 | 0% | 0% | 0% | 0% | 0% | 0% | |
Quaternary Ammonium Compounds | qac | 23/32 (71.8%) | 8/11 (72.7%) | 8/9 (88.8%) | 3/6 (50%) | 2/3 (66.6%) | 2/3 (66.6%) |